2022年3月18日

Imec, miDiagnostics墨水交易COVID-19“酒精”miDiagnostics許可專利呼吸采樣技術。演示的概念驗證呼吸采樣器。imec的影像。副Editor03.18.22山姆Brusco納電子學和數字技術研究和創新中心imec miDiagnostics,一個imec剝離專業即時測試屏幕,診斷、和監控一係列的健康狀況,已經簽署了一項排他性許可協議。miDiagnostics將啟動商業化努力“COVID-19分析儀”技術,捕捉氣溶膠和水滴從呼出的氣息和屏幕使用miDiagnostics病毒RNA的超快的PCR技術。魯汶大學和大學醫院的臨床研究顯示,呼吸采樣器的捕捉SARS-CoV-2呼出的空氣,快速和可靠的病毒RNA decetion。Imec也開發了一種采樣儀器集成呼吸采樣技術和Imec的超高速PCR測試。“我注意非常驕傲,我們在過去幾個月運行一個令人印象深刻的課程,“呂克·範舉起,首席執行官在imec告訴記者。“我們已經成功地將一個有前途的概念和開創性的技術轉化成功能性概念驗證已通過用戶測試和臨床研究。這是第一次,我們已經走了這麼遠我們的芯片技術發展的走向商業化。有了這個概念,我們可以證明——接近市場——我們的技術的附加值,同時大大降低了上市時間為我們的合作夥伴。 The license agreement with miDiagnostics is an important milestone for imec: our breakthrough technology will help curb the COVID-19 pandemic in the foreseeable future." Imec aims to develop the platform further so it can be used to diagnose other infectious airborne diseases. “Despite the vaccination campaigns, there’s still a great need for accessible and reliable rapid tests to curb new virus outbreaks or to avoid unnecessary quarantine. With our license to imec's groundbreaking technology, we aim to make our ultra-fast PCR technology, which we now use for nasal swabs, also compatible with exhaled air—the perfect sample for silicon-based PCR. This first prototype will be tested at the airport in November in collaboration with Brussels Airport, Ecolog and Eurofins,” said Katleen Verleysen, CEO of miDiagnostics. Charles Sternberg, Associate Editor 03.18.22 Michael Barbella, Managing Editor 03.18.22 Charles Sternberg, Associate Editor 03.17.22 Sam Brusco, Associate Editor 03.17.22 Charles Sternberg, Associate Editor 03.14.22 Michael Barbella, Managing Editor 03.11.22 Sam Brusco, Associate Editor 03.08.22 Sam Brusco, Associate Editor 03.01.22 Sam Brusco, Associate Editor 02.28.22 Sam Brusco, Associate Editor 02.24.22 ID Tech Molecular 02.24.22 Charles Sternberg, Associate Editor 02.22.22 Sam Brusco, Associate Editor 02.18.22 Sam Brusco, Associate Editor 02.17.22